CD47 and cancer: Functional relevance of CD47 overexpression is indicated by our data; although gefitinib down-regulates CD47 and increases ecto-CRT in almost all cell lines tested, it is the decrement of CD47 that results in enhanced phagocytosis of cancer cells by dendritic cells.